Clinical Trial Update: Intrathecal Bolus Doses of Ziconotide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating intrathecal bolus doses of ziconotide in peripheral neuropathy has completed. No results are detailed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Ziconotide (ziconotide)

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Peripheral Neuropathy | Phase 4 | Status: COMPLETED